Cargando…
Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019
Invasive group A Streptococcus (iGAS) infections have increased in Israel since 2016 as successful lineages have emerged. We report the emergence and outbreak of a multidrug-resistant S. pyogenes emm93.0, sequence type 10, among iGAS infections in Israel since 2017. This type has been observed very...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714194/ https://www.ncbi.nlm.nih.gov/pubmed/34932442 http://dx.doi.org/10.3201/eid2801.210733 |
_version_ | 1784623868083699712 |
---|---|
author | Ron, Merav Brosh-Nissimov, Tal Korenman, Zinaida Treygerman, Orit Sagi, Orli Valinsky, Lea Rokney, Assaf |
author_facet | Ron, Merav Brosh-Nissimov, Tal Korenman, Zinaida Treygerman, Orit Sagi, Orli Valinsky, Lea Rokney, Assaf |
author_sort | Ron, Merav |
collection | PubMed |
description | Invasive group A Streptococcus (iGAS) infections have increased in Israel since 2016 as successful lineages have emerged. We report the emergence and outbreak of a multidrug-resistant S. pyogenes emm93.0, sequence type 10, among iGAS infections in Israel since 2017. This type has been observed very rarely in other countries. During this period, emm93.0 was the cause of 116 infections in Israel and became the leading type during 2018. Most of the infections were from bacteremia (75%), and most patients were male (76%). We observed infections across Israel, mainly in adults. Of note, we observed multidrug resistance for clindamycin, tetracycline, and trimethoprim/sulfamethoxazole. Whole-genome sequencing confirmed clonality among geographically disseminated isolates. The local emm93.0 sequence type 10 clone contained a novel genomic island harboring the resistance genes lsa(E), lnu(B), and ant (6)-Ia aph(3′)-III. Further phenotypic and genomic studies are required to determine the prevalence of this resistance element in other iGAS types. |
format | Online Article Text |
id | pubmed-8714194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-87141942022-01-04 Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 Ron, Merav Brosh-Nissimov, Tal Korenman, Zinaida Treygerman, Orit Sagi, Orli Valinsky, Lea Rokney, Assaf Emerg Infect Dis Research Invasive group A Streptococcus (iGAS) infections have increased in Israel since 2016 as successful lineages have emerged. We report the emergence and outbreak of a multidrug-resistant S. pyogenes emm93.0, sequence type 10, among iGAS infections in Israel since 2017. This type has been observed very rarely in other countries. During this period, emm93.0 was the cause of 116 infections in Israel and became the leading type during 2018. Most of the infections were from bacteremia (75%), and most patients were male (76%). We observed infections across Israel, mainly in adults. Of note, we observed multidrug resistance for clindamycin, tetracycline, and trimethoprim/sulfamethoxazole. Whole-genome sequencing confirmed clonality among geographically disseminated isolates. The local emm93.0 sequence type 10 clone contained a novel genomic island harboring the resistance genes lsa(E), lnu(B), and ant (6)-Ia aph(3′)-III. Further phenotypic and genomic studies are required to determine the prevalence of this resistance element in other iGAS types. Centers for Disease Control and Prevention 2022-01 /pmc/articles/PMC8714194/ /pubmed/34932442 http://dx.doi.org/10.3201/eid2801.210733 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Ron, Merav Brosh-Nissimov, Tal Korenman, Zinaida Treygerman, Orit Sagi, Orli Valinsky, Lea Rokney, Assaf Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 |
title | Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 |
title_full | Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 |
title_fullStr | Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 |
title_full_unstemmed | Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 |
title_short | Invasive Multidrug-Resistant emm93.0 Streptococcus pyogenes Strain Harboring a Novel Genomic Island, Israel, 2017–2019 |
title_sort | invasive multidrug-resistant emm93.0 streptococcus pyogenes strain harboring a novel genomic island, israel, 2017–2019 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714194/ https://www.ncbi.nlm.nih.gov/pubmed/34932442 http://dx.doi.org/10.3201/eid2801.210733 |
work_keys_str_mv | AT ronmerav invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019 AT broshnissimovtal invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019 AT korenmanzinaida invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019 AT treygermanorit invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019 AT sagiorli invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019 AT valinskylea invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019 AT rokneyassaf invasivemultidrugresistantemm930streptococcuspyogenesstrainharboringanovelgenomicislandisrael20172019 |